Apex benzodiazo salt assay set - Taiwan Registration 6b20d3d4a42dae81b8486ac6b9d118bd
Access comprehensive regulatory information for Apex benzodiazo salt assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6b20d3d4a42dae81b8486ac6b9d118bd and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is a homogeneous enzyme immunoassay for the qualitative and/or semi-quantitative detection of benzodiazepines and their metabolites in human urine at a threshold concentration of 200 ng/mL (0.700 ฮผmol/L) on the Alinity c analyzer.
A Clinical chemistry and clinical toxicology
A.3200 Clinical Toxicology Corrector;; A.3170 Benzodiazo salt test system
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Jan 28, 2021
Jan 28, 2026